Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases

Int J Hematol. 2022 Oct;116(4):579-585. doi: 10.1007/s12185-022-03397-7. Epub 2022 Jul 10.

Abstract

Chylous effusion is associated with lymphatic obstruction or leakage in mediastinal or abdominal lymph nodes, and is a rare but troublesome complication in patients with malignant lymphomas. Although there is no standard of care, it is often treated with simultaneous chemotherapeutic and non-chemotherapeutic interventions. Here, we describe the cases of five patients with lymphoma-associated chylothorax with the aim of clarifying an effective treatment strategy. All patients achieved a partial response or better for lymphoma. All patients underwent interventional radiology (IVR) procedures, including lymphangiography (LAG) and thoracic duct embolization (TDE). Complete resolution of chylothorax was eventually achieved by IVR procedures or pleurodesis in all patients. No patients experienced serious adverse events related to LAG/TDE. Treatment of chylous effusion required months for most patients (range: 0.2-4.8 months). Our data suggest that a combination of chemotherapy and LAG/TDE is effective for refractory lymphoma-related chylous effusion.

Keywords: Chemotherapy; Chylous effusion; Lymphangiography; Lymphoma; Thoracic duct embolization.

Publication types

  • Case Reports

MeSH terms

  • Chylothorax* / diagnostic imaging
  • Chylothorax* / etiology
  • Chylothorax* / therapy
  • Embolization, Therapeutic* / methods
  • Humans
  • Lymphoma* / complications
  • Lymphoma* / pathology
  • Lymphoma* / therapy
  • Radiology, Interventional
  • Thoracic Duct / pathology